10 Einträge gefunden

1. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

   1. Burdelski, Christoph
   2. Kleinhans, Sandra
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE
2. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

   1. Melling, Nathaniel
   2. Taskin, B
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
3. Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers

   1. Burdelski, Christoph
   2. Barreau, Ysé
   3. Simon, Ronald
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
4. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

   1. Burdelski, Christoph
   2. Strauss, Christian
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Lebok, Patrick

   2015 - Forschungsinformationssystem des UKE
5. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
6. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

   1. Burdelski, Christoph
   2. Reiswich, V.
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2015 - Forschungsinformationssystem des UKE
7. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
8. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

   1. Tsourlakis, Maria Christina
   2. Khosrawi, Puya
   3. Weigand, Philipp
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
9. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

   1. Burdelski, Christoph
   2. Bujupi, Erzen
   3. Tsourlakis, Maria Christina
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Melling, Nathaniel
   7. Lebok, Patrick

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
10. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

    1. Grupp, Katharina
    2. Sanader, Stella
    3. Sirma, Hüseyin
    4. Simon, Ronald
    5. Koop, Christina
    6. Prien, Kristina
    7. Hube-Magg, Claudia

    2013 - Forschungsinformationssystem des UKE - frei zugänglich